Monotherapy with interferon-α, or combination therapy with interferon-α, interleukin-2 and 5-fluorouracil for metastatic renal cell carcinoma

被引：0
|
作者：
不详
机构：
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2006年 / 5卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [1] Interleukin-2, interferon-α and 5-fluorouracil immunotherapy for metastatic renal cell carcinoma:: The all Ireland experience
    O'Brien, MF
    Rea, D
    Rogers, E
    Bredin, H
    Butler, M
    Grainger, R
    McDermott, TED
    Mullins, G
    O'Brien, A
    Twomey, A
    Thornhill, J
    [J]. EUROPEAN UROLOGY, 2004, 45 (05) : 613 - 619
  • [2] Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma:: a multicenter phase II study
    van Herpen, CML
    Jansen, RLH
    Kruit, WHJ
    Hoekman, K
    Groenewegen, G
    Osanto, S
    De Mulder, PHM
    [J]. BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 772 - 776
  • [3] Immunochemotherapy with interleukin-2, interferon-α and 5-fluorouracil for progressive metastatic renal cell carcinoma: A multicenter phase II study
    Van Herpen C.M.L.
    Jansen R.L.H.
    Kruit W.H.J.
    Hoekman K.
    Groenewegen G.
    Osanto S.
    De Mulder P.H.M.
    [J]. British Journal of Cancer, 2000, 82 (4) : 772 - 776
  • [4] Pilot trial of infusional 5-fluorouracil, interleukin-2, and subcutaneous interferon-α for advanced renal cell carcinoma
    Elias, L
    Binder, M
    Mangalik, A
    Clark, D
    Morrison, B
    Altobelli, KK
    Smith, A
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (02): : 156 - 161
  • [5] Progressive anemia following combination therapy with interferon-α and interleukin-2 in a patient with metastatic renal cell carcinoma
    Hosokawa, Y
    Kishino, T
    Ono, T
    Oyama, N
    Hayashi, K
    Momose, H
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (10) : 906 - 908
  • [6] Interleukin-2, interferon-α and medroxyprogesterone acetate in metastatic renal cell carcinoma
    Naglieri, E
    Lopez, M
    Lelli, G
    Morelli, F
    Amodio, A
    Di Tonno, P
    Gebbia, N
    Di Seri, M
    Chetri, MC
    Rizzo, P
    Abbate, I
    Casamassima, A
    Selvaggi, FP
    Colucci, G
    [J]. ANTICANCER RESEARCH, 2002, 22 (05) : 3045 - 3051
  • [7] A Phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-α in patients with metastatic renal cell carcinoma
    Ryan, CW
    Vogelzang, NJ
    Stadler, WM
    [J]. CANCER, 2002, 94 (10) : 2602 - 2609
  • [8] T-cell subpopulation in patients with metastatic renal cell carcinoma treated by recombinant interleukin-2, recombinant interferon-α, 5-fluorouracil, and vinblastine
    Gez, E
    Mekori, T
    Struminger, L
    Rubinov, R
    Nativ, O
    Stein, A
    Haim, N
    Kuten, A
    [J]. CANCER INVESTIGATION, 1999, 17 (04) : 259 - 263
  • [9] Interleukin-2, interferon-α and interleukin-2 plus interferon-α in renal cell carcinoma.: A randomized phase II trial
    Boccardo, F
    Rubagotti, A
    Canobbio, L
    Galligioni, E
    Sorio, R
    Lucenti, A
    Cognetti, F
    Ruggeri, E
    Landonio, G
    Baiocchi, C
    Besana, C
    Citterio, G
    De Rosa, M
    Calabresi, F
    [J]. TUMORI, 1998, 84 (05) : 534 - 539
  • [10] Metastatic jejunal VIPoma:: Beneficial effect of combination therapy with interferon-α and 5-fluorouracil
    Cellier, C
    Yaghi, C
    Cuillerier, E
    Siauve, N
    Berger, A
    Carnot, F
    Haddad, C
    Barbier, JP
    Landi, B
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (01): : 289 - 293
12345